Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMG-007 in Adult Alopecia Areata
NCT06060977Phase 2Completed
- Start
- Sep 2023
- Primary completion
- Jan 2025
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of IMG-007 in alopecia areata. Started Sep 2023; status: completed.
02
Drugs
IMG-007
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT06060977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06060977.